<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00537992</url>
  </required_header>
  <id_info>
    <org_study_id>FR-CI-03-2007</org_study_id>
    <nct_id>NCT00537992</nct_id>
  </id_info>
  <brief_title>Blue-Blocking IOLs in Combined Surgery</brief_title>
  <official_title>Blue Light-Filter IOLs in Vitrectomy Combined With Cataract Surgery: Results of a Randomized Controlled Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although commonly used in cataract surgery, the use of the blue light-filter IOLs in
      vitrectomy combined with cataract surgery has not been reported yet. A prospective controlled
      clinical trial was designed to evaluate the effect of the blue light-filter IOL on the
      surgeon's ability to perform specific vitreoretinal procedures and on the patients' outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sixty patients were randomly assigned to receive a UV-filter IOL (transparent IOL group) or a
      blue light-filter IOL (yellow IOL group) combined with a vitreoretinal procedure.

      Outcome measures were intraoperative conditions for the surgeon, complication rates, the
      functional outcome and vitreoretinal diagnoses.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2004</start_date>
  <completion_date type="Actual">March 2006</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intraoperative conditions for the surgeon (scaled questionnaire) and patientsÂ´ outcome</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>complication rates and vitreoretinal diagnoses</measure>
  </secondary_outcome>
  <enrollment type="Actual">60</enrollment>
  <condition>Epiretinal Membranes</condition>
  <condition>Macular Holes</condition>
  <condition>Cataract</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>combined surgery</intervention_name>
    <description>UV-filter IOL (transparent IOL group) or a blue light-filter IOL (yellow IOL group) combined with a vitreoretinal procedure</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis vitreoretinal pathology (diabetic vitreous hemorrhage, macular hole,
             epiretinal membrane or persisting macula edema)

          -  Coexisting significant cataract

          -  The need for combined surgery ( pars plana vitrectomy, phacoemulsification and IOL
             implantation)

          -  Age over 50 years.

        Exclusion Criteria:

          -  Pseudophakia on the non-study eye

          -  The need for silicone oil tamponade

          -  Optic atrophy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susanne Binder, Prof., MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christiane I Falkner-Radler, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ludwig Boltzmann Institute for Retinology and Biomicroscopic Laser Surgery</affiliation>
  </overall_official>
  <reference>
    <citation>Hayashi K, Hayashi H. Visual function in patients with yellow tinted intraocular lenses compared with vision in patients with non-tinted intraocular lenses. Br J Ophthalmol. 2006 Aug;90(8):1019-23. Epub 2006 Apr 5.</citation>
    <PMID>16597662</PMID>
  </reference>
  <reference>
    <citation>Olson RJ, Werner L, Mamalis N, Cionni R. New intraocular lens technology. Am J Ophthalmol. 2005 Oct;140(4):709-16. Epub 2005 Jul 18. Review.</citation>
    <PMID>16023990</PMID>
  </reference>
  <verification_date>October 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 1, 2007</study_first_submitted>
  <study_first_submitted_qc>October 1, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2007</study_first_posted>
  <last_update_submitted>October 1, 2007</last_update_submitted>
  <last_update_submitted_qc>October 1, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2007</last_update_posted>
  <keyword>combined surgery,</keyword>
  <keyword>cataract surgery,</keyword>
  <keyword>vitrectomy,</keyword>
  <keyword>blue light-filter iols</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Retinal Perforations</mesh_term>
    <mesh_term>Epiretinal Membrane</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

